USFDA issues 2 observations for Dr Reddy's Labs Srikakulam facility Ruchika Sharma8 July 2022 11:31 AM ISTNew Delhi: Drugmaker, Dr Reddy's Laboratories, has recently announced that the United States Food & Drug Administration (USFDA) has...
Dr Reddy's Labs unit inks drug discovery, development pact with EQRx Ruchika Sharma5 July 2022 11:31 AM ISTThe parties would share both fundings for the discovery and development of the programmes and financials resulting from the commercialisation of any...
Dr Reddys Labs settles patent litigation with Aquestive Therapeutics, Indivior Ruchika Sharma30 Jun 2022 6:15 PM ISTThe said agreement resolves all claims between the parties relating to the company's generic buprenorphine and naloxone sublingual film, 2 mg/0.5 mg,...
JB Pharma acquires 4 pediatric brands from Dr Reddys Ruchika Sharma30 Jun 2022 12:19 PM ISTThe acquisition has been done for a cash consideration of Rs 98.3 crores.
Dr Reddys acquires injectable product portfolio from Eton Pharma for Rs 391 crore Ruchika Sharma25 Jun 2022 11:49 AM IST"The acquisition supports Dr. Reddy's efforts to accelerate and expand affordable medications for patients," the company stated.
LIC shareholding in Dr Reddy's crosses 5 percent mark Ruchika Sharma17 Jun 2022 3:00 PM ISTThis translates into an investment of Rs 1,556.41 crore to buy over 33.3 lakh shares of the pharma company.
Dr Reddy's Labs unveils Sorafenib Tablets in US Ruchika Sharma14 Jun 2022 2:42 PM ISTDr Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.
Dr Reddys arm, Olema Pharma ink pact to develop novel cancer therapies Ruchika Sharma10 Jun 2022 12:10 PM ISTDuring the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Dr Reddys to sell Finast, Styptovit-E and 2 other brands to Torrent Pharma Ruchika Sharma27 May 2022 12:21 PM ISTAs per the terms of the definitive agreement, Torrent Pharma will take over the manufacturing, marketing and distribution of these brands in India.
Dr Reddys, Senores Pharma unveil Ketorolac Tromethamine Tablets in US Ruchika Sharma25 May 2022 11:57 AM ISTDr. Reddy’s Ketorolac Tromethamine Tablets USP, 10 mg, are available in bottle count sizes of 100.
Dr Reddys Labs, HK inno.N Corporation ink pact to commercialize Tegoprazan in India, 6 key emerging Markets Ruchika Sharma12 May 2022 12:19 PM ISTThe agreement grants Dr. Reddy's the exclusive rights to develop and commercialise Tegoprazan under its own trademark in these markets for 10 years...
Ex Dr Reddys President Saumen Chakraborty joins Premas Biotech Board of Directors Ruchika Sharma10 May 2022 11:30 AM ISTSaumen Chakraborty retired as the President and Chief Financial Officer of Dr Reddy’s in 2020 and served as an Advisor to them for the next year.
